Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Mirum Pharmaceuticals has raised $600.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2026.
Mirum Pharmaceuticals's investors include Novo Holdings, TCG Crossover, New Enterprise Associates, Frazier Healthcare Partners, Rock Springs Capital.
Mirum Pharmaceuticals is headquartered in Foster City, United States.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Mirum Pharmaceuticals is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mirum Pharmaceuticals — Funding & Investors." VCBacked, May 12, 2026, https://www.vcbacked.co/company/mirum-pharmaceuticals. Accessed July 19, 2026.
VCBacked. (2026). Mirum Pharmaceuticals — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/mirum-pharmaceuticals
{{cite web |title=Mirum Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/mirum-pharmaceuticals |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated